Success Stories: NIW Approved for Pharmaceutical Science Researcher Advancing Drug Analysis and Natural Product Therapeutics

Client’s Testimonial:

“Thank you so much for your support, and it has been a great pleasure to work with you.”

On July 12^th, 2025, we received another approval of EB‑2 NIW (National Interest Waiver) for an Assistant Professor in the Field of Pharmaceutical Science (Approval Notice).

General Field: Pharmaceutical Science

Position at the Time of Case Filing: Assistant Professor

Country of Origin: Bangladesh

Country of Residence at the Time of Filing: Bangladesh

Approval Notice Date: July 12^th, 2025

Processing Time: 1 year, 6 months, 4 days

Case Summary:

We are pleased to share the success story of an EB‑2 NIW approval for a researcher whose work in pharmaceutical science has both substantial merit and national importance. At filing, the client was employed as a research scientist focusing on drug analysis and also lecturing in pharmaceutical sciences, and had already established a strong record of high‑impact publications and peer-reviewed service.

Research Focus and Contributions

The petition detailed the client’s innovative program, which includes:

Probing drug‑protein interactions to elucidate binding dynamics and enhance predictive models of drug efficacy
Unveiling the phytochemical composition and therapeutic potential of plant extracts for anti‑inflammatory, analgesic, and antimicrobial applications
Conducting pharmacological profiling of multiple natural products to identify novel bioactive compounds
Developing and validating analytical methods, including UV‑spectroscopic assays to characterize drug potency and purity in support of patient safety and pharmacovigilance

Research Impact and Metrics

To demonstrate the national interest and unique qualifications, the petition highlighted:

26 total publications (24 peer‑reviewed journal articles and 2 accepted journal articles)
133 citations reflecting widespread adoption of her methodologies in pharmaceutical and biomedical research
Invitations to serve as a peer reviewer for multiple leading journals in pharmaceutical science, underscoring her expert standing in the field

These quantitative benchmarks, together with expert testimonials, underscored the client’s original contributions of major significance and her capacity to advance critical drug‑analysis technologies.

Here is a compelling excerpt from one of the recommendation letters that highlights how the client’s research benefits the United States:

“In bioassays of wild currant leaf extracts, the [client’s] cytotoxicity testing revealed that the ethyl acetate fraction exhibited pronounced toxicity, while antibacterial assays showed the n‑hexane fraction potently inhibited microbial growth, underscoring the extract’s diverse pharmacological activities and potential as a source of novel therapeutic compounds.”

Demonstrating Substantial Merit & National Importance

Evidence showed that improved drug‑analysis methods directly address urgent public‑health needs by ensuring patient safety, supporting pharmacovigilance efforts, and reducing the economic burden of product recalls through more reliable quality‑control strategies. Independent letters confirmed that this work aligns with U.S. priorities for enhancing therapeutic efficacy and safeguarding the drug supply chain.

Well‑Positioned to Advance the Proposed Endeavor

The petition documented the client’s rigorous academic background, including a Ph.D. in pharmaceutical chemistry, and her dual roles in industry and academia, demonstrating both technical expertise and leadership in drug‑development research. Expert letters praised her ability to integrate analytical chemistry, natural‑product pharmacology, and regulatory compliance frameworks to drive continued innovation in drug safety and quality

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.